FDA Approved: JADENU — Supplemental Application (Novartis Pharmaceuticals Corporation)

View source ↗

Summary

The FDA approved a supplemental application for JADENU (deferasirox) from Novartis Pharmaceuticals, authorizing changes to its labeling related to iron overload…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Iron Overload Due to Transfusion

Drugs mentioned

• JADENU (deferasirox)

Snippet

SUPPL AP for JADENU (DEFERASIROX)